Sunshine Biopharma (SBFM) Inventory (2019 - 2026)

Sunshine Biopharma has reported Inventory for 8 years, with the latest figure at $13.2 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 11.06% year-over-year to $13.2 million; the trailing twelve-month figure through Mar 2026 stood at $13.2 million (up 11.06% YoY), and the FY2025 full-year result was $13.5 million, up 19.45% from the prior year.
• Inventory for Q1 2026 stood at $13.2 million, down from $13.5 million in the prior quarter.
• The five-year high for Inventory was $14.1 million in Q3 2025, with the low at $181496.0 in Q1 2022.
• Historically, Inventory has averaged $7.4 million across 5 years, with a median of $7.7 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory soared 3014.0% — and 2026, when it grew 11.06%.
• Sunshine Biopharma's Inventory stood at $3.3 million in 2022, then jumped by 74.31% to $5.7 million in 2023, then soared by 96.66% to $11.3 million in 2024, then grew by 19.45% to $13.5 million in 2025, then slipped by 2.25% to $13.2 million in 2026.
• The last three Inventory figures came in at $13.2 million (Q1 2026), $13.5 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.